1cP-MIPLA

Last updated

1cP-MIPLA
1cP-MIPLA.svg
Clinical data
Other names1cP-MiPLA; 1-Cyclopropanoyl-MIPLA; 1-Cyclopropanoyl-N-methyl-N-isopropyllysergamide; 1-(Cyclopropanecarbonyl)-N,6-dimethyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide
Routes of
administration 		Oral [1] [2] [3]
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-4-(cyclopropanecarbonyl)-N,7-dimethyl-N-(propan-2-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C24H29N3O2
Molar mass 391.515 g·mol−1
3D model (JSmol)
  • CN1C[C@@H](C=C2[C@H]1Cc1cn(c3c1c2ccc3)C(=O)C1CC1)C(=O)N(C(C)C)C
  • InChI=1S/C24H29N3O2/c1-14(2)26(4)23(28)17-10-19-18-6-5-7-20-22(18)16(11-21(19)25(3)12-17)13-27(20)24(29)15-8-9-15/h5-7,10,13-15,17,21H,8-9,11-12H2,1-4H3/t17-,21-/m1/s1
  • Key:DBIYDHUGEKMIHZ-DYESRHJHSA-N

1cP-MIPLA, also known as 1-cyclopropanoyl-MIPLA or 1-cyclopropanoyl-N-methyl-N-isopropyllysergamide, is a drug of the lysergamide family. [1] [2] [3] It is the 1-cyclopropanoyl derivative of MIPLA (N-methyl-N-isopropyllysergamide). [1] [2] [3] 1cP-MIPLA has been encountered as a novel designer drug online [1] and in Japan. [2] [3]

Contents

The drug is assumed to act as a prodrug of MIPLA via deacylation. [2] [3] Relatedly, it is assumed to act as a serotonin receptor agonist, including of the serotonin 5-HT2A receptor, and to be a serotonergic psychedelic. [1] 1cP-MIPLA has been sold in the form of blotter tabs containing doses of 200 μg per tab. [1] Data on the effects of 1cP-MIPLA at different doses are not available. [1]

1cP-MIPLA was first encountered as a designer drug online in 2020 [1] and in Japan by 2022. [2] [3] The drug is a schedule I controlled substance in Russia. [1]

See also

References

  1. 1 2 3 4 5 6 7 8 9 "1cP-MIPLA". АИПСИН (in Russian). Retrieved 26 July 2025.
  2. 1 2 3 4 5 6 Tanaka R, Kawamura M, Mizutani S, Kikura-Hanajiri R (2022). "Analyses of LSD analogs in illegal products: The identification of 1cP-AL-LAD, 1cP-MIPLA and 1V-LSD". Toxicologie Analytique et Clinique. 34 (3): S171. Bibcode:2022ToxAC..34Q.171T. doi: 10.1016/j.toxac.2022.06.295 .
  3. 1 2 3 4 5 6 Tanaka R, Kawamura M, Mizutani S, Kikura-Hanajiri R (2023). "Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products" (PDF). Forensic Toxicology. 41 (2): 294–303. doi: 10.1007/s11419-023-00661-1 . ISSN   1860-8965. PMC   10310582 . PMID   36809464 . Retrieved 26 July 2025.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.